Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
SPDR S&P Pharmaceuticals ETF Stock Price, Quotes and Forecasts
XPHARCA
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
158.44M
Fund Score
SPDR S&P Pharmaceuticals ETF Price, Quotes and Forecasts | ARCA:XPH | Benzinga
Explore SPDR S&P Pharmaceuticals ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for XPH.
| Open | $39.67 |
| High | $39.78 |
| 52 Wk High | $48.76 |
| AUM | 158.44M |
| Dividend | $0.62 |
| Ex-Div Date | Jun 24, 2024 |
| Volume | 18.95K |
| Market Cap | $64.78B |
| Mgmt Fee | 0.35% |
| P/E Ratio | 17.98 |
| Prev. Close | $40.69 |
| Low | $38.64 |
| 52 Wk Low | $38.88 |
| Shares Out | 4.85M |
| Yield | 1.48% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 50.77K |
| Beta | 0.76 |
| Avg. Expense Ratio | 0.35% |
| P/B Ratio | 2.69 |
Recent News
FAQ
Q
How do I buy SPDR S&P Pharmaceuticals ETF (XPH) stock?
A
You can purchase shares of SPDR S&P Pharmaceuticals ETF (ARCA:XPH) through any online brokerage.
Q
Who are SPDR S&P Pharmaceuticals ETF (XPH) competitors?
A
There are no as such competitors for SPDR S&P Pharmaceuticals ETF.
Q
What is the forecast, or price target, for SPDR S&P Pharmaceuticals ETF (XPH) stock?
A
There is no analysis for SPDR S&P Pharmaceuticals ETF to provide a consensus price target.
Q
What is the current price for SPDR S&P Pharmaceuticals ETF (XPH)?
A
The stock price for SPDR S&P Pharmaceuticals ETF (ARCA: XPH) is $39.43 last updated April 4, 2025 at 11:25 AM EDT.
Q
Does SPDR S&P Pharmaceuticals ETF (XPH) pay a dividend?
A
A quarterly cash dividend of 0.05 per share of Class A Common Stock. The quarterly cash dividend was payable on September 27, 2018 to stockholders of record on September 24, 2018.
Q
When is SPDR S&P Pharmaceuticals ETF (ARCA:XPH) reporting earnings?
A
SPDR S&P Pharmaceuticals ETF does not have any upcoming earnings scheduled.
Q
Is SPDR S&P Pharmaceuticals ETF (XPH) going to split?
A
There is no upcoming split for SPDR S&P Pharmaceuticals ETF.
| Open | $39.67 |
| High | $39.78 |
| 52 Wk High | $48.76 |
| AUM | 158.44M |
| Dividend | $0.62 |
| Ex-Div Date | Jun 24, 2024 |
| Volume | 18.95K |
| Market Cap | $64.78B |
| Mgmt Fee | 0.35% |
| P/E Ratio | 17.98 |
| Prev. Close | $40.69 |
| Low | $38.64 |
| 52 Wk Low | $38.88 |
| Shares Out | 4.85M |
| Yield | 1.48% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 50.77K |
| Beta | 0.76 |
| Avg. Expense Ratio | 0.35% |
| P/B Ratio | 2.69 |
About SPDR Series Trust
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Blend |
| Fund Inception | Jun 19, 2006 |
| Managers | Keith Richardson Karl A. Schneider |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Investment Policy
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI).
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| AXSM | Axsome Therapeutics, I... | 4.70% |
| VTRS | Viatris Inc. | 4.26% |
| ITCI | Intra-Cellular Therapi... | 3.60% |
| BMY | Bristol-Myers Squibb C... | 3.65% |
| PFE | Pfizer, Inc. | 3.76% |
| CORT | Corcept Therapeutics I... | 7.44% |
| JNJ | Johnson & Johnson | 3.65% |
| OGN | Organon & Co | 3.55% |
| CTLT | Catalent, Inc. | 3.84% |
| ZTS | Zoetis, Inc. | 3.65% |
| RPRX | Royalty Pharma | 4.85% |
| LLY | Eli Lilly & Co. | 3.60% |
| JAZZ | Jazz Pharmaceuticals P... | 4.19% |
| PRGO | Perrigo Co. Plc | 3.65% |
| TARS | Tarsus Pharmaceuticals... | 3.71% |
| ELAN | Elanco Animal Health I... | 3.62% |
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2025 Benzinga | All Rights Reserved